1. L.T. Geller, M. Barzily-Rokni, T. Danino, O.H. Jonas, N. Shental, D. Nejman, N. Gavert, Y. Zwang, Z.A. Cooper, K. Shee, C.A. Thaiss, A. Reuben, J. Livny, R. Avraham, D.T. Frederick, M. Ligorio, K. Chatman, S.E. Johnston, C.M. Mosher, A. Brandis, G. Fuks, C. Gurbatri, V. Gopalakrishnan, M. Kim, M.W. Hurd, M. Katz, J. Fleming, A. Maitra, D.A. Smith, M. Skalak, J. Bu, M. Michaud, S.A. Trauger, I. Barshack, T. Golan, J. Sandbank, K.T. Flaherty, A. Mandinova, W.S. Garrett, S.P. Thayer, C.R. Ferrone, C. Huttenhower, S.N. Bhatia, D. Gevers, J.A. Wargo, T.R. Golub, R. Straussman, Potential role of intratumor bacteria in mediating tumor resistance to the chemotherpeutic drug gemcitabine science. 357 (2017) 1156–1160.
2. New peptide-based antimicrobials for tackling drug resistance in bacteria: single-cell fluorescence imaging;Pages;ACS Med. Chem. Lett.,2013
3. Mechanisms of resistance: useful tool to design antibacterial agents for drug-resistant bacteria;Savjani;Mini-Rev. Med. Chem.,2009
4. Design, multigram synthesis, and in vitro and in vivo evaluation of propylamycin: a semisynthetic 4,5-deoxystreptamine class aminoglycoside for the treatment of drug-resistant enterobacteriaceae and other gram-negative pathogens;Matsushita;J. Am. Chem. Soc.,2019
5. Mitochondria-targeted chimeric peptide for trinitarian overcoming of drug resistance;Han;ACS Appl. Mater. Inter.,2016